Eliquis
utilized for stroke prevention to mitigate clotting risks.
Strengths: 2.5 · 5mg
Where to Check Availability
Medicine details
- Therapeutic class
Anticoagulant
- Pharmacological class
Direct Factor Xa Inhibitor
- Precautions and warnings
increased risk of bleeding; discontinue before surgical procedures
- Minor side effects
bruising; nosebleed; nausea
- Moderate side effects
anaemia; gastrointestinal haemorrhage
- Serious side effects
intracranial haemorrhage — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
utilized for stroke prevention to mitigate clotting risks.
- Prescription status
POM
- Manufacturer
Bristol-Myers Squibb
- Onset Time
1–3 hours
- Duration
12 hours
- Storage instructions
Store in the original package at room temperature.
- Drug interactions
aspirin; clopidogrel; ketoconazole
- Age restrictions
Adults only.
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to apixaban; active clinically significant bleeding; hepatic disease associated with coagulopathy
Mechanism of action
Eliquis is an anticoagulant that inhibits factor Xa, a crucial enzyme in the blood coagulation cascade. By blocking this factor, the medication prevents the formation of harmful blood clots, helping reduce the risk of stroke or systemic embolism in patients with specific cardiac conditions.
Eliquis
utilized for stroke prevention to mitigate clotting risks.
Editorial Notes
- Active ingredient(s): Apixaban
- Listed indication(s): Venous Thromboembolism, Atrial Fibrillation, Stroke Prevention